Filter
631
Text search:
FDA
Featured
Recommendations
81
New Publications
120
Language
Document type
No document type
299
Guidelines
167
Studies & Reports
82
Manuals
26
Fact sheets
24
Strategic & Response Plan
17
Training Material
7
Resource Platforms
3
Brochures
2
Situation Updates
2
Infographics
2
Countries / Regions
India
29
Ghana
20
Latin America and the Carribbean
18
Russia
17
Philippines
12
Myanmar / Burma
12
Global
11
South Africa
9
Middle East and North Africa
9
Kenya
8
Brazil
8
Nigeria
7
Congo, Democratic Republic of
7
USA
7
Germany
7
Syria
7
Argentina
7
West and Central Africa
7
Senegal
6
Uganda
6
Ukraine
6
Colombia
6
Ecuador
6
Yemen
6
Western and Central Europe
6
South Sudan
5
Angola
5
Paraguay
5
Eastern Europe
5
Burkina Faso
4
Liberia
4
Mali
4
Ethiopia
4
Indonesia
4
Mozambique
4
Sudan
4
Peru
4
Eastern Europe and Central Asia
4
Guinea
3
Sierra Leone
3
Nepal
3
Tanzania
3
Thailand
3
Rwanda
3
Bangladesh
3
Bolivia
3
East and Southern Africa
3
South–East Asia Region
3
Africa
3
Venezuela
3
France
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Haiti
2
Iraq
2
Jordan
2
Namibia
2
El Salvador
2
Chile
2
Asia
2
Albania
2
Tajikistan
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Zimbabwe
1
Somalia
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
Mauritania
1
Singapore
1
Malawi
1
Benin
1
Dominican Republic
1
Cuba
1
Honduras
1
Botswana
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Armenia
1
Congo-Brazzaville
1
Qatar
1
Moldova
1
Kazakhstan
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
197
Clinical Guidelines
81
Pharmacy & Technologies
23
Women & Child Health
17
Public Health
12
Key Resources
8
Capacity Building
3
Toolboxes
COVID-19
136
Mental Health
71
TB
58
HIV
52
Pharmacy
34
AMR
30
Ebola & Marburg
28
Rapid Response
14
NTDs
14
Specific Hazards
13
NCDs
9
Malaria
9
Zika
8
Refugee
7
Planetary Health
6
Caregiver
4
Cholera
3
Conflict
3
Natural Hazards
3
Global Health Education
2
2.0 Rapid Response
2
Disability
1
Health Financing Toolbox
1
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
Posttraumatic stress disorder (PTSD) in children and adolescents occurs as a result of a child’s exposure to one or more traumatic events: actual or threatened death, serious injury, or sexual violence. The victim may experience the event, witness it, learn about it from close family members or fr
...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T
...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del
...
second edition
Included more self-measured blood pressure (SMBP)-focused content with tools and resources.
Showcased more tools to find patients with potentially undiagnosed HTN.
Added new strategies that focus on chronic kidney disease testing and identification.
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Ciudad de México, México - 26 al 28 de mayo del 2014
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that
...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I
...
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
English Manual and Guideline on World about Food and Nutrition, Health and Epidemic; published on 30 Nov 2021 by USAID
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat
...
